Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is New York Angels' primary investment focus based on their portfolio?
- New York Angels shows a concentration in the Health Tech & Life Sciences sector, with one portfolio company, Nutrino, and two investment rounds in this sector.
- Can you name a notable exit for New York Angels?
- New York Angels had a notable exit with Nutrino, which was acquired by Medtronic in November 2018 for an estimated $100M.
- What is the typical investment range for New York Angels?
- New York Angels' investment range is between $1.5M and $8M per round.
- When did New York Angels make its first recorded investment?
- New York Angels made its first recorded investment in July 2015.
- Has New York Angels acted as a lead investor in any of its disclosed rounds?
- According to startupim data, New York Angels has not acted as a lead investor in any of its disclosed investment rounds.
- Which stages of funding does New York Angels typically participate in?
- New York Angels has participated in Pre-Seed, Seed, and A Round funding stages, with one follow-on investment in an A Round.
- What was New York Angels' most recent investment activity?
- New York Angels' most recent investment was in Nutrino in April 2018, contributing $8,000,000.
- How many new portfolio companies did New York Angels add in 2015?
- New York Angels added one new portfolio company in July 2015.